Literature DB >> 8589558

Cytogenetics of human spermatozoa: what about the reproductive relevance of structural chromosome aberrations?

B E Rosenbusch1.   

Abstract

PURPOSE: The purpose was to review and appreciate data on structural sperm chromosome abnormalities obtained after fusion of human spermatozoa with zona-free hamster eggs.
RESULTS: Breaks and fragments are the predominant sperm chromosome aberrations. In contrast to stable alterations, e.g., translocations, inversions, and deletions that will be transmitted unchanged into following cell generations, breaks, fragments, and some rearrangements have a reduced stability. In proliferating cell systems they will soon be eliminated through formation of lagging chromatin and micronuclei. Their relevance lies in a loss of genetic material or disturbance of cell division that may cause cell death. It is reasonable to assume a responsibility of such aberrations for early unrecognized conception loss. However, this interpretation is subject to criticism because an artifactual origin of sperm chromosome breakage cannot be ruled out.
CONCLUSIONS: The incidence and relevance of structural sperm chromosome abnormalities will remain at issue unless additional and complementary information is provided. For this purpose, new strategies must be developed because further studies employing hamster eggs according to existing protocols will not help resolve the dilemma.

Entities:  

Mesh:

Year:  1995        PMID: 8589558     DOI: 10.1007/bf02215729

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  39 in total

Review 1.  The chromosome complement of human gametes.

Authors:  P A Jacobs
Journal:  Oxf Rev Reprod Biol       Date:  1992

2.  Triploidy after in vitro fertilization: cytogenetic analysis of human zygotes and embryos.

Authors:  M H Pieters; J C Dumoulin; R C Ignoul-Vanvuchelen; M Bras; J L Evers; J P Geraedts
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

3.  Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding.

Authors:  P A Jacobs; C Browne; N Gregson; C Joyce; H White
Journal:  J Med Genet       Date:  1992-02       Impact factor: 6.318

4.  An investigation of human sperm pronuclear chromosome "gaps" using scanning electron microscopy.

Authors:  J E Chernos; J B Rattner; R H Martin
Journal:  Cytogenet Cell Genet       Date:  1986

5.  Direct assessment of the rate of chromosomal abnormalities in grade IV human embryos produced by in-vitro fertilization procedure.

Authors:  F Pellestor; M C Dufour; F Arnal; C Humeau
Journal:  Hum Reprod       Date:  1994-02       Impact factor: 6.918

Review 6.  Treating male infertility needs more clinical andrology, not less.

Authors:  J M Cummins; A M Jequier
Journal:  Hum Reprod       Date:  1994-07       Impact factor: 6.918

7.  A detailed method for obtaining preparations of human sperm chromosomes.

Authors:  R H Martin
Journal:  Cytogenet Cell Genet       Date:  1983

8.  Cytogenetics of human spermatozoa. The frequency of various chromosome aberrations and their relationship to clinical and biological parameters.

Authors:  B Rosenbusch; K Sterzik
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

9.  Are clinical and biological IVF parameters correlated with chromosomal disorders in early life: a multicentric study.

Authors:  M Plachot; A Veiga; J Montagut; J de Grouchy; G Calderon; S Lepretre; A M Junca; J Santalo; E Carles; J Mandelbaum
Journal:  Hum Reprod       Date:  1988-07       Impact factor: 6.918

10.  Chromosome studies in human in vitro fertilization.

Authors:  R R Angell; A A Templeton; R J Aitken
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

View more
  1 in total

1.  Kinetics of human male pronuclear development in a heterologous ICSI model.

Authors:  Estella L Jones; Olga Mudrak; Andrei O Zalensky
Journal:  J Assist Reprod Genet       Date:  2010-03-11       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.